Cargando…

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review

Background Pneumonia is the most common cause of death in children worldwide, accounting for 15% of all deaths of children under 5 years of age. This review summarises the evidence for the empirical antibiotic treatment of community-acquired pneumonia in neonates and children and puts emphasis on pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathur, Shrey, Fuchs, Aline, Bielicki, Julia, Van Den Anker, Johannes, Sharland, Mike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176769/ https://www.ncbi.nlm.nih.gov/pubmed/29790844 http://dx.doi.org/10.1080/20469047.2017.1409455

Ejemplares similares

Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children
por: Fuchs, Aline, et al.
Publicado: (2018)

Global shortage of neonatal and paediatric antibiotic trials: rapid review
por: Thompson, Georgina, et al.
Publicado: (2017)

Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants
por: van Donge, Tamara, et al.
Publicado: (2018)

Global sales of oral antibiotics formulated for children
por: Li, Grace, et al.
Publicado: (2020)

Antibiotic preferences for childhood pneumonia vary by physician type and European region
por: Bielicki, Julia A., et al.
Publicado: (2016)

A comparison of five paediatric dosing guidelines for antibiotics
por: Mathur, Shrey, et al.
Publicado: (2020)

Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing
por: Bielicki, Julia A., et al.
Publicado: (2018)

High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries
por: Bortone, Barbara, et al.
Publicado: (2021)

Harmonization of Amoxicillin Dose, Duration, and Formulation for Acute Childhood Respiratory Infections
por: Dharmapalan, Dhanya, et al.
Publicado: (2023)

Randomised placebo-controlled multicentre effectiveness trial of adjunct betamethasone therapy in hospitalised children with community-acquired pneumonia: a trial protocol for the KIDS-STEP trial
por: Kohns Vasconcelos, Malte, et al.
Publicado: (2020)

2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use
por: Huttner, Benedikt, et al.
Publicado: (2020)

Estimating global trends in total and childhood antibiotic consumption, 2011-2015
por: Jackson, Charlotte, et al.
Publicado: (2019)

Antibiotics needed to treat multidrug-resistant infections in neonates
por: Williams, Phoebe CM, et al.
Publicado: (2022)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

Variation in Target Attainment of Beta‐Lactam Antibiotic Dosing Between International Pediatric Formularies
por: Gastine, Silke, et al.
Publicado: (2021)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia
por: Lee, Mi Suk, et al.
Publicado: (2018)

Clinical response to antibiotic therapy for community-acquired pneumonia
por: Juvén, Taina, et al.
Publicado: (2004)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
por: da Fonseca Lima, Eduardo Jorge, et al.
Publicado: (2016)

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT)
por: Lyttle, Mark D, et al.
Publicado: (2019)

Community-acquired and nosocomial pneumonia
por: Herold, Christian J., et al.
Publicado: (2004)

Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children
por: Rodrigues, Charlene M.C.
Publicado: (2017)

Analysis of antibiotic usage for viral community-acquired pneumonia in adults
por: Jiang, Rongmeng, et al.
Publicado: (2020)

Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy
por: Liang, Junyu, et al.
Publicado: (2020)

Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines
por: Clements, Michelle N., et al.
Publicado: (2021)

Lipoid pneumonia presenting as non resolving community acquired pneumonia: a case report
por: Hadda, Vijay, et al.
Publicado: (2009)

Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department
por: Carrie, Anita G, et al.
Publicado: (2005)

Overprescription of antibiotics in patients with community-acquired pneumonia in the intensive care unit
por: Hooten, Rorak, et al.
Publicado: (2019)

Viewing the Community-acquired Pneumonia Guidelines through an Antibiotic Stewardship Lens
por: Fabre, Valeria, et al.
Publicado: (2020)

The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia
por: Nguyen, Phuong T. K., et al.
Publicado: (2023)

Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care
por: Saatchi, Ariana, et al.
Publicado: (2023)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

Validation of an electronic algorithm to identify appropriate antibiotic use for community-acquired pneumonia in children
por: Chiotos, Kathleen, et al.
Publicado: (2023)

Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools
por: van den Anker, John, et al.
Publicado: (2019)

Insufficient Stability of Clavulanic Acid in Widely Used Child-Appropriate Formulations
por: Mack, Ines, et al.
Publicado: (2021)

Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga MD, Ane, et al.
Publicado: (2020)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7fl55qut7tmuian7jpjka4hg90